LKFT Strangle Strategy
LKFT (Lakefront Biotherapeutics N.V.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Galapagos NV is a biotechnology company that specializes in the discovery and advancement of novel small molecule and antibody-based therapeutics. Its active clinical development programs include drugs like filgotinib and GLP3667, alongside the Toledo program and therapies targeting idiopathic pulmonary fibrosis. The firm was established on June 30, 1999, by co-founders Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es, and maintains its headquarters in Mechelen, Belgium.
LKFT (Lakefront Biotherapeutics N.V.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.84B, a trailing P/E of 3.27, a beta of 0.12 versus the broader market, a 52-week range of 25.68-37.78, average daily share volume of 176K, a public-listing history dating back to 2005, approximately 452 full-time employees. These structural characteristics shape how LKFT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.12 indicates LKFT has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. The trailing P/E of 3.27 is on the value side, where IV often compresses outside event windows because forward growth expectations are already discounted into the share price.
What is a strangle on LKFT?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
LKFT snapshot
As of August 14, 2026, spot at $27.53, ATM IV 63.20%, expected move 18.12%. The strangle on LKFT below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this strangle structure on LKFT specifically: IV rank is unavailable in the current snapshot, so regime-based timing for LKFT is inferred from ATM IV at 63.20% alone, with a market-implied 1-standard-deviation move of approximately 18.12% (roughly $4.99 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated LKFT expiries trade a higher absolute premium for lower per-day decay. Position sizing on LKFT should anchor to the underlying notional of $27.53 per share and to the trader's directional view on LKFT stock.
LKFT strangle setup
The LKFT strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With LKFT at $27.53 on that close, the first option leg uses a $28.91 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed LKFT chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 LKFT shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $28.91 | N/A |
| Buy 1 | Put | $26.15 | N/A |
LKFT strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
LKFT strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on LKFT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on LKFT
Strangles on LKFT are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the LKFT chain.
LKFT thesis for this strangle
The market-implied 1-standard-deviation range for LKFT extends from approximately $22.54 on the downside to $32.52 on the upside. A LKFT long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. As a Healthcare name, LKFT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to LKFT-specific events.
LKFT strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. LKFT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move LKFT alongside the broader basket even when LKFT-specific fundamentals are unchanged. Always rebuild the position from current LKFT chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on LKFT?
- A strangle on LKFT is the strangle strategy applied to LKFT (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With LKFT stock at $27.53 on the most recent close, the strikes shown on this page are snapped to the nearest listed LKFT chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are LKFT strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the LKFT strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 63.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a LKFT strangle?
- The breakeven for the LKFT strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The LKFT market-implied 1-standard-deviation expected move in the same options snapshot is approximately 18.12%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on LKFT?
- Strangles on LKFT are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the LKFT chain.
- How does current LKFT implied volatility affect this strangle?
- Current LKFT ATM IV is 63.20%; IV rank context is unavailable in the current snapshot.